Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Tacrolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 102 Myelodysplastic Syndromes 100 Precursor Cell Lymphoblastic Leukemia-Lymphoma 89 Leukemia 71 Hodgkin Disease 67 Lymphoma, Non-Hodgkin 64 Multiple Myeloma 63 Lymphoma 63 Leukemia, Lymphocytic, Chronic, B-Cell 62 Myeloproliferative Disorders 46 Graft vs Host Disease 46 Lymphoma, Follicular 44 Leukemia, Myeloid, Accelerated Phase 41 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 41 Hematologic Neoplasms 41 Lymphoma, Mantle-Cell 40 Lymphoma, Large B-Cell, Diffuse 40 Leukemia, Myelomonocytic, Chronic 39 Congenital Abnormalities 36 Burkitt Lymphoma 36 Lymphoma, B-Cell, Marginal Zone 35 Leukemia, Myeloid, Chronic-Phase 34 Primary Myelofibrosis 33 Blast Crisis 32 Neoplasms, Plasma Cell 31 Lymphoma, Large-Cell, Immunoblastic 29 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 21 Waldenstrom Macroglobulinemia 20 Myelodysplastic-Myeloproliferative Diseases 20 Lymphoma, T-Cell, Cutaneous 20

Interventions

Carboplatin 695 Pemetrexed 535 Cisplatin 484 Paclitaxel 431 pembrolizumab 409 Docetaxel 391 Gemcitabine 286 Erlotinib Hydrochloride 282 Radiotherapy 226 Bevacizumab 213 Nivolumab 212 osimertinib 152 durvalumab 143 Drug Therapy 140 Gefitinib 120 atezolizumab 117 Radiosurgery 112 Vinorelbine 98 Cetuximab 84 130-nm albumin-bound paclitaxel 83 Magnetic Resonance Spectroscopy 80 Taxes 71 Ipilimumab 70 Surgical Procedures, Operative 66 Albumin-Bound Paclitaxel 61 Afatinib 58 Specimen Handling 57 Cyclophosphamide 56 tislelizumab 54 Etoposide 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06120140 2026-03-13

COCOON

Janssen Research & Development, LLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡